Publish your website RSS Feed on ooBdoo
click here

---

---

Publish your website
RSS Feed on ooBdoo
visit our publish page

---

ScienceDaily: Headache Research News Thu, 02 Sep 2010 12:05:01 EDT Head start for migraine sufferers Psychological migraine treatment gives sufferers a confidence boost in their ability to self-manage their symptoms. For severe migraine sufferers, psychological treatments build on the benefits of drug therapy, according to a new study. A comparison of the effects of various treatment combinations for severe migraine - drug therapy with or without behavioral management - shows that those patients receiving the behavioral management program alongside drug therapy are significantly more confident in their ability to use behavioral skills to effectively self-manage migraines. Thu, 02 Sep 2010 00:00:00 EDT First genetic link to common migraine exposed Researchers have found the first ever genetic risk factor associated with common types of migraine. The team found that patients with the DNA variant have a significantly greater risk for developing migraine and suggest that an accumulation of a chemical known as glutamate in nerve cell junctions in the brain may play a key role in the initiation of migraine attacks. The research opens the door for new studies into migraine in humans. Mon, 30 Aug 2010 11:00:00 EDT Migraine sufferers have higher risk of dying from heart disease and stroke, research finds Individuals who suffer from migraines with aura (temporary visual or sensory disturbances before or during a migraine headache) are at a higher risk of dying from heart disease or stroke, according to new research. Wed, 25 Aug 2010 14:00:00 EDT Headaches in teens tied to overweight, smoking and lack of exercise Teens who are overweight, get little exercise or who smoke may be more likely to have frequent headaches and migraines than teens with none of these factors, according to a new study. Thu, 19 Aug 2010 08:00:00 EDT Solving the mystery of bone loss from drug for epilepsy and bipolar disorder Scientists are reporting a possible explanation for the bone loss that may occur following long-term use of a medicine widely used to treat epilepsy, bipolar disorder, and other conditions. The drug, valproate, appears to reduce the formation of two key proteins important for bone strength. Fri, 06 Aug 2010 08:00:00 EDT

---

 

 

---

Medical News Today: Headache/Migraine News

Headache / Migraine News From Medical News Today Thu, 02 Sep 2010 18:53:59 +0200 Botox Maker Allergan Agrees To Pay $600 Million And Pleads Guilty To Misdemeanor Allergan Inc., the makers of BOTOX (onabotulinumtoxinA) announced that it has agreed to pay US $600 million and to plead guilty to misdemeanor, thus reaching a resolution with the DOJ (US Department of Justice) regarding a previously reported Government investigation into the company's past sales and marketing practices related to specific therapeutic uses of BOTOX... Wed, 01 Sep 2010 11:00:00 PDT Genetic Link To Migraine Found, In DNA Variant On Chromosome 8 Scientists have identified the first genetic risk factor linked to a common type of migraine after examining the genetic data of over 50,000 individuals. The investigators say that this breakthrough gives them new insights into migraine triggers, which will hopefully lead to novel therapies to prevent episodes of migraine... Mon, 30 Aug 2010 10:00:00 PDT Recurrent Teen Headaches Linked To Smoking, Overweight And Physical Inactivity Teenagers who regularly have headaches may find that their problem is linked to overweight, smoking and/or lack of physical exercise, according to an article published in the medical journal Neurology. The authors found that teenagers with all three factors - those who were overweight, smoked and did very little exercise - were 3... Thu, 19 Aug 2010 08:00:00 PDT Headaches In Teens Tied To Overweight, Smoking And Lack Of Exercise Teens who are overweight, get little exercise or who smoke may be more likely to have frequent headaches and migraines than teens with none of these factors, according to a study published in the August 18, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. Teens with all three of the negative lifestyle factors were 3... Thu, 19 Aug 2010 04:00:00 PDT Nautilus Neurosciences Announces U.S. Launch Of CAMBIA(TM) (Diclofenac Potassium For Oral Solution) For The Treatment Of Migraine Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced that CAMBIA(TM) (diclofenac potassium for oral solution) is now available in the United States for the acute treatment of migraine with or without aura. CAMBIA was approved by the U.S. Food and Drug Administration in June 2009... Sat, 07 Aug 2010 02:00:00 PDT BOTOX(R) Receives First Authorisation In UK As Preventative Treatment In Chronic Migraine Allergan has today announced that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine)1... Mon, 12 Jul 2010 04:00:00 PDT HeadCoolieTM Adjustable, Reusable Head Wrap Provides Non-Chemical, Non-Prescription Therapeutic Relief For Fever Symptoms And Headaches American Diversified Medical Corporation, a majority owned subsidiary of ThermaFreeze Products Corporation (PINKSHEETS: TZPC), unveiled its newest product line, the HeadCoolie™... Fri, 09 Jul 2010 02:00:00 PDT A Simple Massage Is Proven To Relieve Psychological And Physiological State Of Patients With Chronic Tension Headache Researchers at the University of Granada -in collaboration with the Clinical Hospital San Cecilio and the University Rey Juan Carlos- have proven that the psychological and physiological state of patients with tension headache improves within 24 hours after receiving a 30-minute massage. As researchers explained, tension headaches have an increasing incidence in the population... Fri, 09 Jul 2010 02:00:00 PDT GlaxoSmithKline And XenoPort Report Top-Line Phase 2b Results For GSK1838262/XP13512 As A Prophylactic Treatment For Migraine Headache GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches... Fri, 09 Jul 2010 01:00:00 PDT REM Sleep Deprivation Plays A Role In Chronic Migraine Reporting at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week, new research shows that sleep deprivation leads to changes in the levels of key proteins that facilitate events involved in the underlying pathology of migraine. Paul L. Dunham, Ph.D... Thu, 24 Jun 2010 00:00:00 PDT

 

---